Navigation Links
TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
Date:5/14/2009

PM ICD/CRT infection infection Implant Type implants infections rate implants infections rate De novo 15 0 0.0% 51 0 0.0% Revision 38 0 0.0% 141 1 0.4% Total 53 0 0.0% 192 1 0.4% Other Total infection infection Implant Type implants infections rate implants infections rate De novo 1 0 0.0% 67 0 0.0% Revision 8 0 0.0% 187 1 0.4% Total 9 0 0.0% 254 1 0.4%

Dr. Dan Lerner, TYRX's Chief Medical Officer, noted that "when one looks at the characteristics of the patients enrolled in the AIGIS Retrospective Registry to-date it is noteworthy that there is a high percentage of patients who are, according to published studies, at high risk of CRMD-related infections."

                                                             Greater than
                                                             or equal to 1
                                                              Follow-up
       Risk Factors for developing a CRMD       All            Visit
                    infection                 n = 393          n = 254
                                              n     %         n      %
                                     CHF     218   55.5      152    59.8

             Chronic Renal Insufficiency      93   23.7       56    22.1

                   Chronic Renal Failure      41   10.4       24     9.5

                     Oral anti-coagulant     140   35.6       90    35.4

'/>"/>
SOURCE TYRX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
3. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Calif. and VIENNA, Va. ... innovative in-home care provider that operates in ... a leading provider of remote caregiving technology. Alta will ... and existing client receiving homecare services. Logo ... this technology is the key to providing the kind ...
(Date:11/21/2014)... Fla. , Nov. 21, 2014   Rock ... announced that the Company is scheduled to present at ... San Francisco, CA on January 12-14, 2015. ... Chairman and CEO of Rock Creek Pharmaceuticals, will present ... molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. ...
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... instruments and consumables for the medical, research, and veterinary ... veterinary and research markets in the United ... stock purchase agreement to acquire 100% of QCR & ... based distribution organization. The transaction closed on November ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... 16, 2007 - Amgen,(Nasdaq:AMGN) today presented the results ... the,efficacy and safety of Aranesp(R) (darbepoetin alfa) for ... not receiving,chemotherapy or radiotherapy ("the 103 study"). Aranesp ... EMEA in these patients. These,results were presented in ...
... WIRE)--Apr 16, 2007 - Arsenic, a naturally,occurring element, ... years, and even now remains a venerable constituent ... to the efforts of investigators supported,by grants from ... Walls," an arsenic derivative is being,utilized in therapy ...
Cached Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3
(Date:11/24/2014)... 2014 Dr. Michael Kettel , a ... appeared on NBC to discuss egg freezing as a viable ... trending in the news recently, with new company benefits at ... , “[The companies] see it as a way ... career hot path.” Says Dr. Kettel. , Up until a ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled its new ... are now offered at deeply discounted prices, up to 75 ... Dec. 15. The main purpose of the promotion is to ... items are ideal options for ladies who are eager to ... its new mint cocktail dresses are very beautiful; they are ...
(Date:11/23/2014)... 24, 2014 Tbdress.com has recently ... online on Nov. 28, 2014. The special offer will provide ... Tbdress.com is one of the world’s largest women’s dresses retailers, ... colors. People can enjoy great discounts on that day: Everything ... free delivery (for orders above $89). , People can use ...
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 This ... such as its significance, programs and manufacturing technological ... Chinese suppliers major market gamers in information. In ... item specifications, prospective, manufacturing value, and 2009-2014 market ... the evaluation symbolizes the globally and Chinese suppliers ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... Sept. 11 Bupa,s Latin America and Caribbean,operation -- ... --,announced today the launch of the international Ecuador Challenge, ... where many families survive on,average on just $4 a ... will,travel to Ecuador until November 29 to build essential ...
... FRANKLIN, Mass., Sept. 11 PLC Systems Inc. ... cardiac and vascular medical device-based technologies, today provided an ... the annual meeting of the European Society of Cardiology, ... More than 30,000 clinicians and professionals attended this ...
... , Flu Clinic Locator Available on ... Seasonal Flu Vaccination Clinics and Stay Healthy , , ... easier for people to get their seasonal flu vaccine this year with ... of public seasonal influenza vaccination clinics is now available at ...
... , , LIBERTYVILLE, Ill., Sept. ... believed to be exterminated nationwide, the teeny, insidious bloodsuckers--which feast on ... , They,re being spotted in hotels from coast to ... and upscale chains. In a recent study of 700 mid-priced hotels, ...
... death rates alone doesn,t measure severity of cases, researchers say ... questions the value of hospital report cards and national rankings ... Loyola University Health System in Chicago say the mortality index, ... has in a given area of medical care, may be ...
... , CUPERTINO, Calif., Sept. 11 -- DURECT ... has entered into a privately negotiated transaction to sell 4,444,444 ... a price of $2.25 per share, raising net proceeds to ... to close on or about September 18, 2009, subject to ...
Cached Medicine News:Health News:Bupa Launches its 2009 International Charity Challenge to Help a Rural Community in Ecuador 2Health News:PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009 2Health News:PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009 3Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 2Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 3Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 4Health News:Rest Easy, the Safe, All-Natural Bed Bug Travel Spray 2Health News:Report Cards for Hospitals May Be Misleading 2Health News:DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million 2
... Volu-Sol's New Methylene Blue, ... to use. This stain ... does not require any counter-staining. ... in three different sizes, 30 ...
... in methanol for faster, more complete ... smears. Our special manufacturing process yields ... elements producing unequaled definition of cytoplasmic ... brilliance in the resulting smear. Used ...
... Volu-Sol's Stat Stain is ideal for stat, ... stain blood smears (10-15 seconds) and bone ... generates finely dispersed stain particles which yield ... eliminates many of the steps involved in ...
... single-solution staining, Hema-Quik II for ... into stain solution for five ... deionized water for five to ... time by dipping quickly in ...
Medicine Products: